NervGen Pharma Corp. Common stock (NGEN)

NervGen Pharma Corp. Common stock (NGEN) is listed on Nasdaq, where it has traded since March 25, 2019.

Listed On
Nasdaq
Listed Since
March 25, 2019
Employees
9
Market Cap
$205M

About NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 62 institutions reported holding NGEN, with 12.0 million shares worth $24.9 million in aggregate. The largest reported holder was Empery Asset Management, with 4.0 million shares worth $8.2 million. Of the 5 largest holders listed below, all 5 opened new positions in NGEN during the quarter.

InstitutionSharesValueQuarter change
Empery Asset Management4,000,000$8MNew position
Rock Springs Capital Management1,208,231$2MNew position
Dafna Capital Management1,050,000$2MNew position
Ghisallo Capital Management1,000,000$2MNew position
Armistice Capital678,000$1MNew position

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is NGEN?

NervGen Pharma Corp. Common stock (NGEN) is listed on Nasdaq, where it has traded since March 25, 2019.

Who are the largest institutional holders of NGEN?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of NGEN were Empery Asset Management, Rock Springs Capital Management and Dafna Capital Management.

How many institutions own NGEN?

62 institutions reported a position in NGEN for the quarter ended June 30, 2026, worth $24.9 million in total.

Did institutions buy or sell NGEN last quarter?

Of the 5 largest reported holders, all 5 opened new positions in NGEN during the quarter. Every reported holder and its change is on the SentiSense ownership page for NGEN.

Every reported institutional holder, plus insider and congressional trades in NGEN, on SentiSense.